KRYS filings
Corporate insider profile
Suma Krishnan Filing Activity
Latest reported as President, R&D of Krystal Biotech, Inc. (KRYS).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$7,702,825.00
- Latest transaction
- Jun 4, 2026
Affiliated corporations
Reported company relationships
Transaction history